Product Introduction: TELKONOL -TRIO

TELKONOL -TRIO is a high-efficacy triple combination anti-hypertensive medication. Composed of 40mg of Telmisartan, 10mg of Cilnidipine, and 12.5mg of Chlorthalidone, it is indicated for the treatment of severe essential hypertension when double combination therapy is insufficient, lowering blood pressure and reducing cardiovascular risks.

Primary Indications

• Treatment of essential hypertension (high blood pressure).
• Prevention of cardiovascular disease, reducing stroke and heart attack risk.
• Management of hypertension in patients with left ventricular hypertrophy.

Clinical Benefits

• Triple Action: Telmisartan relaxes blood vessels, Cilnidipine dilates peripheral arteries, and Chlorthalidone promotes water excretion.
• Renoprotection: Cilnidipine blocks L/N-type calcium channels, protecting kidneys from high pressure.
• Once-Daily Convenience: Offers reliable 24-hour blood pressure control with a single daily tablet.

Possible Side Effects

Common side effects may include:

• Dizziness, fatigue, headache, or orthostatic hypotension.
• Electrolyte imbalances, such as hypokalemia or hyponatremia.
• Mild gastrointestinal discomfort or transient renal impairment.

How to Take TELKONOL -TRIO

• Take one tablet daily, with or without food, preferably in the morning.
• Swallow the tablet whole with a glass of water.
• Do not stop taking the drug abruptly, as blood pressure can rise quickly.

Mechanism of Action

TELKONOL -TRIO works through three distinct mechanisms:

• Telmisartan: Selectively blocks the angiotensin II AT1 receptor, inhibiting vasoconstriction and aldosterone release.
• Cilnidipine: Blocks L-type and N-type calcium channels, suppressing sympathetic nerve activity and causing blood vessels to dilate.
• Chlorthalidone: Inhibits sodium and chloride reabsorption in the renal distal convoluted tubule, increasing water and salt excretion.

Safety Warnings

• Pregnancy & Nursing: Strictly contraindicated. Angiotensin blockers can cause fetal injury or death.
• Liver Health: Use with caution in hepatic impairment.
• Kidney Health: Monitor renal function regularly, especially in patients with renal artery stenosis.

Patient Advice

• Avoid standing up too quickly from a sitting or lying position to prevent dizziness.
• Monitor your blood pressure regularly and keep a record.
• Avoid potassium supplements or salt substitutes unless directed by your physician.

Fact Box

Drug Interactions

• Simvastatin: Limit simvastatin dose to 20mg daily when taking amlodipine.
• NSAIDs (Ibuprofen): May reduce the blood-pressure-lowering effect.
• Potassium-Sparing Diuretics: May cause severe hyperkalemia.

User Feedback

• Patients report highly satisfactory blood pressure control, with a significant reduction in dizziness.
• Highly recommended by clinicians as a reliable combination therapy for essential hypertension.